Skip to main content

Peptic Ulcer Disease

2
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

AstraZeneca
AstraZenecaCAMBRIDGE, United Kingdom
2 programs
2
Esomeprazole/ASA Fixed CombinationPhase 11 trial
Esomeprazole/ASA Fixed CombinationPhase 11 trial
Active Trials
NCT00998075Completed138Est. Dec 2009
NCT01015729Terminated30Est. Mar 2010
Integrated Biosciences
Integrated BiosciencesCA - San Carlos
1 program
Hou Gu Mi XiN/A1 trial
Active Trials
NCT03320538Completed360Est. Sep 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
AstraZenecaEsomeprazole/ASA Fixed Combination
AstraZenecaEsomeprazole/ASA Fixed Combination
Integrated BiosciencesHou Gu Mi Xi

Clinical Trials (3)

Total enrollment: 528 patients across 3 trials

NCT01015729AstraZenecaEsomeprazole/ASA Fixed Combination

Study Comparing Esomeprazole and ASA Combined Together as One Capsule Versus These Medications Taken Separately

Start: Nov 2009Est. completion: Mar 201030 patients
Phase 1Terminated
NCT00998075AstraZenecaEsomeprazole/ASA Fixed Combination

Study Comparing Esomeprazole and Acetylsalicylic Acid (ASA) Combined Together as One Capsule Versus These Medications Taken Separately

Start: Sep 2009Est. completion: Dec 2009138 patients
Phase 1Completed
NCT03320538Integrated BiosciencesHou Gu Mi Xi

Efficacy and Safety of Hou Gu Mi Xi in Patients With Peptic Ulcer Diseases

Start: Jul 2017Est. completion: Sep 2020360 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.